MP:0000062 | increased bone density | "increased mineral content of bone; indicator of bone strength" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:61295] |
Show
Allelic Composition: ComtB2i/Comt+ Genetic Background: Boulder heterogeneous stock
|
MP:0000063 | reduced bone density | "decreased mineral content of bone; indicator of bone strength" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, MGI:CLS, J:57315] |
Show
Allelic Composition: Nab2tm1b(EUCOMM)Hmgu/Nab2tm1b(EUCOMM)Hmgu Genetic Background: C57BL/6N-Nab2tm1b(EUCOMM)Hmgu/Ics
|
MP:0001541 | abnormal osteoclast function | "reduced ability or inability of osteoclasts to absorb and remove osseous tissue" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, J:58795] |
Show
Allelic Composition: ComtB2i/Comt+ Genetic Background: Boulder heterogeneous stock
|
MP:0001876 | decreased inflammatory response | "less than expected response to injury, infection, or insult" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Pdia3Gt(RST613)Byg/Pdia3Gt(RST613)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0003795 | abnormal bone structure | |
Show
Allelic Composition: ComtB2i/Comt+ Genetic Background: Boulder heterogeneous stock
|
MP:0005293 | impaired glucose tolerance | "less than the normal response to oral consumption or intravenous injection of specified amounts of glucose and indicative of insulin resistance; measured by determining whole blood or plasma sugar level in a fasting state before and after taking glucose at specified intervals" [MeSH:National Library of Medicine - Medical Subject Headings , 2003] |
Show
Allelic Composition: Nab2tm1b(EUCOMM)Hmgu/Nab2tm1b(EUCOMM)Hmgu Genetic Background: C57BL/6N-Nab2tm1b(EUCOMM)Hmgu/Ics
|
MP:0005605 | increased bone mass | "an increase in the total amount of bone tissue contained in the skeleton" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: ComtB2i/Comt+ Genetic Background: Boulder heterogeneous stock
|
MP:0008088 | abnormal T-helper 1 cell differentiation | "atypical production of or inability to produce the subset of the type of T-helper cell whose cytokine production favors cellular immune responses and delayed type hypersensitivity" [CL:0000545, ISBN:0781735149, MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Pdia3Gt(RST613)Byg/Pdia3Gt(RST613)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008092 | abnormal T-helper 2 cell differentiation | "atypical production of or inability to produce the type of T-helper cell whose cytokine production promotes defense against extracellular parasites and humoral immune responses typical of allergy" [CL:0000546, ISBN:0781735149, MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Pdia3Gt(RST613)Byg/Pdia3Gt(RST613)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008158 | increased diameter of femur | "increased width of the cross-sectional distance that extends from one lateral edge of the femur, through its center and to the opposite lateral edge" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: ComtB2i/Comt+ Genetic Background: Boulder heterogeneous stock
|
MP:0008160 | increased diameter of humerus | "increased width of the cross-sectional distance that extends from one lateral edge of the humerus, through its center and to the opposite lateral edge" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: ComtB2i/Comt+ Genetic Background: Boulder heterogeneous stock
|
MP:0008395 | abnormal osteoblast differentiation | "atypical production of or inability to produce bone-forming cells, which normally form an osseous matrix (osteoid) in which they become enclosed as an osteocytes" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: ComtB2i/Comt+ Genetic Background: Boulder heterogeneous stock
|
MP:0008567 | decreased interferon-gamma secretion | "reduction in the production or release of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Pdia3Gt(RST613)Byg/Pdia3Gt(RST613)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008673 | decreased interleukin-13 secretion | "reduction in the production or release of a cytokine synthesized by T-cells that produces proliferation, immunoglobulin isotype switching, and immunoglobulin production by immature B-cells, and appears to play a role in regulating inflammatory and immune responses" [MESH:D12.644.276.374.465.513] |
Show
Allelic Composition: Pdia3Gt(RST613)Byg/Pdia3Gt(RST613)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008700 | decreased interleukin-4 secretion | "reduction in the production or release of a soluble factor produced by activated T-cells that induces the expression of MHC class II genes and FC receptors on B-cells and causes their proliferation and differentiation; it also acts on T-cells, mast cells and several other hematopoietic lineage cells" [MESH:D12.644.276.374.465.504] |
Show
Allelic Composition: Pdia3Gt(RST613)Byg/Pdia3Gt(RST613)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0008703 | decreased interleukin-5 secretion | "reduction in the production or release of a cytokine that promotes differentiation and activation of eosinophils; it also triggers activated B-cells to differentiate into immunoglobulin-secreting cells" [MESH:D12.644.276.374.465.505] |
Show
Allelic Composition: Pdia3Gt(RST613)Byg/Pdia3Gt(RST613)Byg Genetic Background: involves: 129P2/OlaHsd * C57BL/6
|
MP:0010124 | decreased bone mineral content | "reduction in the amount (usually in grams/cm) of bone mineral divided by a bone-scanned area" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Nab2tm1b(EUCOMM)Hmgu/Nab2tm1b(EUCOMM)Hmgu Genetic Background: C57BL/6N-Nab2tm1b(EUCOMM)Hmgu/Ics
|
MP:0010867 | abnormal bone trabecula morphology | "any structural anomaly of the network of intersecting plates and spicules in cancellous bone which form a meshwork of intercommunicating spaces filled with blood vessels and marrow; in mature bone, the trabeculae are aligned in parallel with the lines of major compressive or tensile force" [http://www.dorlands.com/ "Dorland s Illustrated Medical Dictionary, 31st edition", MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: ComtB2i/Comt+ Genetic Background: Boulder heterogeneous stock
|
MP:0010868 | increased bone trabecula number | "increased number of intersecting plates and spicules in cancellous bone which form a meshwork of intercommunicating spaces filled with blood vessels and marrow; in mature bone, the trabeculae are aligned in parallel with the lines of major compressive or tensile force" [http://www.dorlands.com/ "Dorland s Illustrated Medical Dictionary, 31st edition", MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: ComtB2i/Comt+ Genetic Background: Boulder heterogeneous stock
|
MP:0010878 | increased trabecular bone volume | "increase in the amount of space occupied by trabecular bone tissue in the skeleton" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: ComtB2i/Comt+ Genetic Background: Boulder heterogeneous stock
|
MP:0010929 | increased osteoid thickness | "increase in the width of the layer of newly formed organic bone matrix secreted by osteoblasts" [ISBN:0-683-40008-8 "Stedman s Medical Dictionary, 27th edition"] |
Show
Allelic Composition: ComtB2i/Comt+ Genetic Background: Boulder heterogeneous stock
|
MP:0020039 | increased bone ossification | "increase in the formation of bone or of a bony substance, or the conversion of fibrous tissue or of cartilage into bone or a bony substance" [ORCID: orcid.org/0000-0003-4606-0597] |
Show
Allelic Composition: ComtB2i/Comt+ Genetic Background: Boulder heterogeneous stock
|